When Elon Musk worked on X question Mark Cuban steps in with some hard truths about why Americans are “not getting their money’s worth,” even though the U.S. leads the world in healthcare administrative costs. . Known for his outspokenness and deep insight into health care reform, Mr. Cuban has given Mr. Musk and other CEOs short-term guidance on how their decisions will directly impact the cost and quality of health care in the United States. An intensive course was held.
“The key is the contract signed by the CEO of the self-insurer,” Cuban wrote in response to Musk’s tweet. He said many of these contracts, particularly those with pharmacy benefit managers (PBMs), are currently The roots of rising costs and inadequate care.
Don’t miss:
Mr. Cuban listed seven major issues with typical PBM contracts that affect not only companies such as Mr. Musk’s Tesla and SpaceX, but also their employees and families.
-
No control over billing data: Businesses do not have complete access to data about billing or payments.
-
Restricted formulations: PBMs control which drugs are covered and often prioritize profit over health.
-
Expensive “specialty medicines”: Prices are often increased for no good reason.
-
Rebates come at a price. “Kickbacks” paid by drug companies ultimately increase deductibles and out-of-pocket costs for employees, hitting the sickest and the elderly hardest.
-
Harming independent pharmacies: PBMs often reimburse small pharmacies for less than the price of brand-name drugs, forcing many pharmacies out of business.
-
No collaboration with manufacturers: Companies cannot work directly with drug manufacturers to create targeted wellness programs.
-
Opaque contracts: Many PBM contracts include NDAs, making the system inefficient and nationwide price.
